查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566866

颅内压 (ICP) 监测市场：按技术、按应用、按最终用户：2024-2033 年全球机会分析和产业预测

Intracranial Pressure Monitoring Market By Technique, By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

颅内压 (ICP) 监测市场

2023年颅内压（ICP）监测市值为4亿美元，预计2024年至2033年复合年增长率为5.1%，到2033年将达6亿美元。

ICP 监测是一种诊断测试，可测量颅腔内某些液体（例如脑脊髓液或血液）产生的颅内压。将导管或感测器插入大脑中的脑脊髓液空间以测量压力。进行 ICP 监测对于多种医疗状况至关重要，包括中风、创伤性脑损伤、脑肿瘤和神经系统疾病。透过 ICP 监测，医疗保健提供者可以评估脑损伤的强度，识别颅内动态的变化，并做出治疗决策。

由于技术的不断进步，ICP监测有效性的快速提高是市场的主要驱动因素。无线连接、感测器小型化以及与数位健康平台的整合使医疗保健提供者能够收集即时资料、做出明智的决策并改善神经关键环境中的患者照护。未来，非侵入性ICP监测有望成为医疗保健领域的主流。目前正在快速进行研究和开发工作，以减轻现有非侵入性手术的局限性，例如经颅都卜勒超音波超音波、脑组织共振和静脉血压计。

然而，最尖端科技的进步导致诊断测试变得更加昂贵，并且对许多人来说遥不可及。此外，采购ICP监测相关设备的初始成本较高，加上校准、维护和耗材成本，使得中小型医疗机构难以投资。相反，人工智慧的引入是一个创新领域，有望为颅内压（ICP）监测市场开闢新途径。人工智慧有望分析设备产生的大型资料集，并识别人类观察可能跳过的异常情况。人工智慧预测模型提供的提案预计将支援按时提供医疗回应，从而改善患者的治疗结果。

分部审查

颅内压 (ICP) 监测市场分为技术、应用、最终用户和地区。依手术方式分为侵入式和非侵入式。依用途分为脑外伤、脑出血、脑膜炎等。依最终用户划分，可分为医院、诊所、私人医疗机构、创伤中心和政府/研究机构。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

主要发现

以手术方式来看，2023 年非侵入式手术的收益最高。

从应用来看，创伤性脑损伤细分市场在 2023 年的收益最高。

从最终用户来看，医院细分市场将在 2023 年获得更高的市场份额。

可以自订此报告（需要额外的费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章颅内压（ICP）监测市场：依技术分类

  • 市场概况
  • 侵入性的
  • 非侵入性

第五章颅内压（ICP）监测市场：依应用分类

  • 市场概况
  • 脑外伤
  • 脑出血
  • 脑膜炎
  • 其他的

第六章颅内压 (ICP) 监测市场：依最终使用者分类

  • 市场概况
  • 医院
  • 诊所
  • 私人诊所
  • 创伤中心
  • 政府机构和研究机构

第七章颅内压（ICP）监测市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国颅内压（ICP）监测市场
    • 加拿大颅内压（ICP）监测市场
    • 墨西哥颅内压（ICP）监测市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国颅内压（ICP）监测市场
    • 德国颅内压（ICP）监测市场
    • 义大利颅内压（ICP）监测市场
    • 西班牙颅内压（ICP）监测市场
    • 英国颅内压（ICP）监测市场
    • 其他欧洲国家颅内压 (ICP) 监测市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国颅内压（ICP）监测市场
    • 日本颅内压（ICP）监测市场
    • 印度颅内压（ICP）监测市场
    • 韩国颅内压（ICP）监测市场
    • 澳洲颅内压（ICP）监测市场
    • 其他亚太地区颅内压 (ICP) 监测市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西颅内压（ICP）监测市场
    • 南非颅内压（ICP）监测市场
    • 沙乌地阿拉伯颅内压（ICP）监测市场
    • 其他拉丁美洲/中东/非洲颅内压 (ICP) 监测市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • BrainLAB
  • Natus Medical Incorporated
  • Integra LifeSciences
  • GE Healthcare
  • Teleflex Incorporated
  • Sick AG
  • Smiths Medical
  • Koninklijke Philips NV
  • Elekta AB
  • AMETEK
简介目录
Product Code: A149770

Intracranial Pressure (ICP) Monitoring Market

The intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

ICP monitoring is a diagnostic test for measuring the pressure inside the skull, exerted by certain fluids such as cerebrospinal fluid and blood within the cranial cavity. A catheter or sensor is inserted into the cerebrospinal fluid space of brain in this procedure to gauge the pressure. Conducting ICP monitoring is pivotal in various medical conditions, including stroke, traumatic brain injury, brain tumors, and neurological disorders. Healthcare providers assess the intensity of brain injury through ICP monitoring, identify modifications in intracranial dynamics, and make treatment decisions.

Surge in the efficacy of ICP monitoring due to continuous technological advancements is a major driver of the market. Wireless connectivity, miniaturization of sensors, and assimilation with digital health platforms have enabled healthcare providers to garner real-time data, make well-informed decisions, and elevate patient care in neurocritical settings. In future, the trend of non-invasive ICP monitoring is projected to dominate in the healthcare settings. Currently, R&D efforts are in full pace to mitigate the limitations of existing non-invasive procedures such as transcranial doppler ultrasonography, brain tissue resonance, and venous ophthalmodynamometry.

However, cutting-edge technological advancements result in high cost of diagnostic tests, making it unaffordable for several individuals. Moreover, the high initial cost of procuring equipment associated with ICP monitoring; along with calibration, maintenance, and consumable expenses; makes it challenging for several small & medium-sized healthcare facilities to invest in them. On the contrary, the deployment of AI is a field of innovation expected to open new avenues for the intracranial pressure (ICP) monitoring market. AI is anticipated to analyze large datasets generated from the equipment and identify the abnormalities that are possible skippable by human observation. Suggestions offered by predictive model of AI are projected to aid in on-time delivery of medical responses, hence improving patient outcomes.

Segment Review

The intracranial pressure (ICP) monitoring market is segmented into technique, application, end user, and region. On the basis of technique, the market is bifurcated into invasive and non-invasive. By application, it is divided into traumatic brain injury, intracerebral hemorrhage, meningitis, and others. Depending on end user, it is classified into hospital, clinics, private medical offices, trauma centers, and government & research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technique, the non-invasive segment generated the highest revenue in the market in 2023.

By application, the traumatic brain injury segment was the highest revenue generator in 2023

Depending on end user, the hospital segment acquired higher stakes of the market in 2023.

Competition Analysis

The major players operating in the global intracranial pressure (ICP) monitoring market include BrainLAB, Natus Medical Incorporated, Integra LifeSciences, GE Healthcare, Teleflex Incorporated, Sick AG, Smiths Medical, Koninklijke Philips N.V, Elekta AB, and AMETEK. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technique

  • Invasive
  • Non-Invasive

By Application

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Others

By End User

  • Hospital
  • Clinics
  • Private Medical Offices
  • Trauma Centers
  • Government and Research Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • BrainLAB
    • Natus Medical Incorporated
    • Integra LifeSciences
    • GE Healthcare
    • Teleflex Incorporated
    • Sick AG
    • Smiths Medical
    • Koninklijke Philips N.V
    • Elekta AB
    • AMETEK

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technique
  • 4.2. Invasive
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non-Invasive
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Traumatic Brain Injury
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Intracerebral Hemorrhage
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Meningitis
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Private Medical offices
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Trauma Centers
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Government And Research Organizations
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Technique
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intracranial Pressure (ICP) Monitoring Market
      • 7.2.6.1. Market Size and Forecast, By Technique
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intracranial Pressure (ICP) Monitoring Market
      • 7.2.7.1. Market Size and Forecast, By Technique
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intracranial Pressure (ICP) Monitoring Market
      • 7.2.8.1. Market Size and Forecast, By Technique
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Technique
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intracranial Pressure (ICP) Monitoring Market
      • 7.3.6.1. Market Size and Forecast, By Technique
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intracranial Pressure (ICP) Monitoring Market
      • 7.3.7.1. Market Size and Forecast, By Technique
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intracranial Pressure (ICP) Monitoring Market
      • 7.3.8.1. Market Size and Forecast, By Technique
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intracranial Pressure (ICP) Monitoring Market
      • 7.3.9.1. Market Size and Forecast, By Technique
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intracranial Pressure (ICP) Monitoring Market
      • 7.3.10.1. Market Size and Forecast, By Technique
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intracranial Pressure (ICP) Monitoring Market
      • 7.3.11.1. Market Size and Forecast, By Technique
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Technique
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intracranial Pressure (ICP) Monitoring Market
      • 7.4.6.1. Market Size and Forecast, By Technique
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intracranial Pressure (ICP) Monitoring Market
      • 7.4.7.1. Market Size and Forecast, By Technique
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intracranial Pressure (ICP) Monitoring Market
      • 7.4.8.1. Market Size and Forecast, By Technique
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intracranial Pressure (ICP) Monitoring Market
      • 7.4.9.1. Market Size and Forecast, By Technique
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intracranial Pressure (ICP) Monitoring Market
      • 7.4.10.1. Market Size and Forecast, By Technique
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intracranial Pressure (ICP) Monitoring Market
      • 7.4.11.1. Market Size and Forecast, By Technique
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Technique
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intracranial Pressure (ICP) Monitoring Market
      • 7.5.6.1. Market Size and Forecast, By Technique
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intracranial Pressure (ICP) Monitoring Market
      • 7.5.7.1. Market Size and Forecast, By Technique
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intracranial Pressure (ICP) Monitoring Market
      • 7.5.8.1. Market Size and Forecast, By Technique
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intracranial Pressure (ICP) Monitoring Market
      • 7.5.9.1. Market Size and Forecast, By Technique
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. BrainLAB
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Natus Medical Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Integra LifeSciences
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. GE Healthcare
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Teleflex Incorporated
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sick AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Smiths Medical
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Elekta AB
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AMETEK
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments